ArticleFrontiers in public health2026
Awareness of HPV, HPV vaccine and associated factors among male junior high school students in Zhejiang Province, China.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: With HPV vaccines for males recently approved in China (2025), this study assessed awareness of HPV and HPV vaccine among junior high school boys in Eastern China, a population underrepresented in research. Methods: A cross-sectional study was conducted in Zhejiang Province in 2023 using multistage cluster sampling. Three cities were purposively selected; within each city, one urban district and one rural county were randomly chosen. A total of six junior high schools (one from each selected district/county) participated in the study, with students randomly sampled from each grade level. Participants completed an anonymous online questionnaire. Univariate and multivariate logistic regression analyses were performed to identify factors associated with awareness of HPV and the HPV vaccine among male junior high school students. Results: Among 1,786 male participants, awareness rates for HPV and the HPV vaccine were 24.7 and 30.7%, respectively. Multivariate analysis revealed factors significantly associated with HPV awareness: urban residence (aOR = 2.20, 95% CI: 1.57-3.08), knowing someone affected by cancer (aOR = 1.40, 95% CI: 1.02-1.92), cervical cancer awareness (aOR = 5.04, 95% CI: 3.48-7.28), HPV vaccine awareness (aOR = 21.31, 95% CI: 15.35-29.60), and concern for partner's cervical cancer risk (aOR = 1.75, 95% CI: 1.23-2.49). Factors significantly associated with HPV vaccine awareness included: knowing someone affected by cancer (aOR = 1.58, 95% CI: 1.18-2.13), cervical cancer awareness (aOR = 2.43, 95% CI: 1.78-3.33), HPV awareness (aOR = 19.84, 95% CI: 14.39-27.36), concern for partner's cervical cancer risk (aOR = 1.47, 95% CI: 1.47-2.91), perceiving being less likely to be infected with HPV (aOR = 1.48, 95% CI: 1.06-2.06), and having received school-based health education on HPV/vaccine (aOR = 2.27, 95% CI: 1.67-3.08). Conclusion: Awareness of HPV and HPV vaccine among junior high school boys in Zhejiang province is low. Targeted interventions, particularly school health programs emphasizing HPV and vaccine knowledge, male HPV risks, the benefits of vaccination, and partner protection, are crucial to improve vaccine uptake in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.